对粘附G蛋白结合受体作为乳腺癌潜在治疗点的相关性研究
Wenning Shi1, Cong Xu2, Ping Lei3
1Department of Protein and Antibody Engineering, School of Pharmacy, Binzhou Medical University, Yantai, 264003, Shandong, China.
粘附G蛋白结合受体 (aGPCRs) 在乳腺癌 (BRCA) 中表达变化. 特定的aGPCRs,如ADGRF2和ADGRF4,是BRCA的有希望的预后生物标志物和潜在的免疫治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 粘附G蛋白结合受体 (aGPCRs) 是一个重要的GPCR子集,参与生理和病理过程.
- 乳腺癌 (BRCA) 仍然是一个全球性的健康挑战,但特定的aGPCR作为治疗点或生物标志物的研究不足.
研究的目的:
- 研究aGPCRs在乳腺癌 (BRCA) 中的作用.
- 为了确定BRCA的aGPCR家族内的潜在的预后生物标志物和治疗点.
主要方法:
- 使用的生物信息学工具 (UALCAN,GEPIA,cBioPortal等) 和RT-qPCR. 这是一个很好的方法.
- 在BRCA中分析了aGPCR的转录水平和生存相关性.
- 进行功能丰富分析以了解aGPCR的作用.
主要成果:
- 在BRCA中确定了几个aGPCR (例如ADGRB2,ADGRC1-3,ADGRE1,ADGRF2,ADGRF4,ADGRL1) 的mRNA水平显著增加.
- 发现aGPCR表达和BRCA病态阶段之间的相关性.
- 在BRCA患者中,ADGRA1,ADGRF2,ADGRF4,ADGRG1-7的高表达与整体存活率 (OS) 和无复发存活率 (RFS) 较差有关.
结论:
- ADGRF2和ADGRF4在BRCA中显示出作为预后生物标志物的巨大潜力.
- 这些特定的aGPCR可以作为乳腺癌治疗的有价值的免疫治疗点.
更多相关视频
08:21Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
G-protein Coupled Receptors
Intracellular Signaling Affects Focal Adhesions
Some...
